Page 329 - ATP-P 11th Ed

®
®
• Anticonvulsant blood levels (e.g., phenytoin [Dilantin ], valproic acid [Depakote ], car-
®
bamazepine [Tegretol ], and phenobarbital) may be reduced by Mefloquine and therefore
risk for convulsions may increase in patients with history of epilepsy. mefloquine itself
has also been associated with convulsions in the absence of anticonvulsant treatment.
TMEP use: Malaria Protocol
®
Meloxicam (Mobic )
Description: NSAID
Indications:
• Relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis.
• Mild to moderate pain relief
Dose: 7.5mg or 15mg daily. The maximum recommended daily oral dose is 15mg.
K9 Dose: Initially 0.2mg/kg PO once daily on day 1 of treatment, then 0.1mg/kg PO
once daily.
Contraindications: Allergy to NSAID class of drugs, aspirin
Pregnancy Category B (1 and 2 trimesters)
st
nd
Pregnancy Category C (3 trimester) SECTION 3
rd
Side-effects:
• Allergic reaction
• Anaphylactoid reactions including shock
• Face edema
• Fatigue
• Fever
• Hot flushes
• Malaise
• Syncope
• Weight decrease
• Weight increase
• Dyspepsia
TMEP use: Pain Management Protocol
®
Metronidazole (Flagyl )
Aviation personnel are grounded for the initial 24hr of antibiotic therapy and until
the medical condition no longer interferes with safely performing aviation duties and the
patient is free of side-effects.
Description: Nitroimidazole antibiotic
Indications: Gastroenteritis presumed due to Giardia
Adult dose:
• Amebic dysentery – 750mg PO tid × 5–10 days

ATP-P Handbook 11th Edition 319